{"id":1276,"date":"2020-08-26T09:33:42","date_gmt":"2020-08-26T09:33:42","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/randox-announces-8-new-external-quality-assurance-programmes\/"},"modified":"2021-01-08T11:10:21","modified_gmt":"2021-01-08T11:10:21","slug":"randox-announces-8-new-external-quality-assurance-programmes","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/randox-announces-8-new-external-quality-assurance-programmes\/","title":{"rendered":"Randox announces 8 new external quality assurance programmes"},"content":{"rendered":"<p>Randox Quality Control announces the launch of 8 new RIQAS EQA Programmes, with cycles scheduled to begin in March 2016. The new programmes are: CSF, Sweat Testing, Immunosuppressants, Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood, Anti-TSH Receptor, Cyfra 21-1. These new RIQAS programmes will provide clinical laboratories with the ability to review calibration issues, systematic errors and monitor accuracy and bias. Furthermore these laboratories will be able to assess their analytical performance in comparison with other laboratories which are employing the same instrument or methods. The new programmes are available in liquid and lyophilized formats, covering the full clinical decision range. Monthly reporting supports the rapid identification of errors and allows implementation of the necessary corrective actions therefore saving the need for expensive and time consuming patient sample retests.&nbsp; Finally the rapid report turnaround will ensure results are received within 24-72 hours and, if required, corrective actions can then be implemented before the next cycle. RIQAS is the largest international EQA scheme used by more than 32,000 laboratory participants in 123 countries. Such large, international peer groups guarantee the statistical validity of the company\u2019s extensive database of instrument and method results.<\/p>\n<link http:\/\/www.randoxqc.com _blank external-link-new-window>www.randoxqc.com<\/link>\n","protected":false},"excerpt":{"rendered":"<p>Randox Quality Control announces the launch of 8 new RIQAS EQA Programmes, with cycles scheduled to begin in March 2016. The new programmes are: CSF, Sweat Testing, Immunosuppressants, Trace Elements in Serum, Trace Elements in Urine, Trace Elements in Blood, Anti-TSH Receptor, Cyfra 21-1. These new RIQAS programmes will provide clinical laboratories with the ability [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"class_list":["post-1276","post","type-post","status-publish","format-standard","hentry","category-e-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1276"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=1276"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1276\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=1276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=1276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=1276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}